@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix chebi: . @prefix species: . @prefix occursIn: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 occursIn: species:9606; rdf:object chebi:26523; rdf:predicate belv:decreases; rdf:subject chebi:3099; a rdf:Statement . sub:assertion rdfs:label "a(CHEBI:bilirubin) -| a(CHEBI:\"reactive oxygen species\")" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_3; pav:version "1.4" . sub:_2 prov:value "HO-1 is a cytoprotective enzyme (6) that degrades the potent prooxidant heme to generate CO and bilirubin. CO is a vasodilatory gas that has anti-proliferative effects on vascular smooth muscle cells (VSMCs) (7) and has anti-inflammatory properties (8). Bilirubin is a scavenger for reactive oxygen species (ROS) (9). In addition, ferrous ion, another product of HO-1, upregulates ferritin, which also has scavenger activity."; prov:wasQuotedFrom pubmed:18633191 . sub:_3 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:18633191; prov:wasDerivedFrom beldoc:, sub:_2 . } sub:pubinfo { this: dct:created "2014-07-03T14:30:53.335+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }